News
Should Investors Hold Old Dominion Stock Despite Its Higher Valuation?
Old Dominion Freight Line, Inc. (ODFL) looks highly unattractive from a valuation standpoint. Considering the forward 12-month price-to-sales ratio (P/S-F12M), ODFL has a forward 12-month P/S-F12M
Qualcomm Just Got Called an AI Loser—So Why Is It Rallying?
Shares of Qualcomm Inc. (NASDAQ: QCOM) were trading up more than 2% on the morning of Wednesday, Dec. 10, marking their longest stretch of gains in months and putting the stock up 12% in just a
NVO Down 42% Year to Date: Is This an Indication to Sell the Stock?
Novo Nordisk NVO has stumbled through 2025, with its shares down 41.5% year to date despite finally resolving U.S. supply constraints for its semaglutide-based GLP-1 blockbusters — Ozempic for type
Pre-markets Mixed Ahead of Consequential Week of Data
Friday, December 12, 2025Pre-market futures are averaging out to be flat at this hour, although we’re seeing a wider band of trading. The blue-chip Dow and the small-cap Russell 2000 — up +110
Can Opdivo's Label Expansions Help Bristol Myers Sustain Its Momentum?
Bristol Myers BMY has a broad oncology portfolio, which includes blockbuster immuno-oncology drugs, Opdivo, Opdivo Qvantig and Yervoy, among others.
Among these, Opdivo (nivolumab) is the top
Can Tesla's New Discounts on Model Y Help Boost Q4 Deliveries?
Electric Vehicle (EV) giant Tesla TSLA has introduced an all-out discount strategy to boost fourth-quarter sales numbers for Model Y. As the company is in the final leg of the year, it is offering a
Synopsys Q4 Earnings Surpass Estimates, Revenues Rise Y/Y
Synopsys SNPS reported non-GAAP earnings of $2.90 per share for the fourth quarter of fiscal 2025, which beat the Zacks Consensus Estimate by 3.94%. The bottom line decreased 14.7% on a
Daktronics' Q2 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Fall
Daktronics DAKT shares fell 1.87% to close at $20.51 on Thursday following second-quarter fiscal 2026 results reported on Dec. 10. Earnings of 35 cents per share surpassed the Zacks Consensus
ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform
AtriCure ATRC recently took a major step forward in surgical ablation innovation with the first patients successfully treated using its new dual-energy platform. The system uniquely pairs Pulsed
Kymera's Eczema Drug Gets Fast Track Designation in the United States
Kymera Therapeutics, Inc. KYMR recently announced that the FDA granted Fast Track designation to pipeline candidate KT-621 for the treatment of moderate to severe atopic dermatitis (AD), the most
Can Verizon's Empower Field Network Infrastructure Upgrade Aid Shares?
Verizon Communications Inc. (VZ) has introduced a new Wi-Fi 6E network at Empower Field at Mile High, home of the Denver Broncos. With Verizon’s upgraded Wi-Fi 6E and LAN, fans can now enjoy a
Clorox's Brand Investments Are Up: Will They Translate to Growth?
The Clorox Company’s CLX brand investments are increasing due to heightened demand creation strategies, including higher trade spending and advertising to support innovations planned for the second
DraftKings' iGaming Up 25%: A Second Growth Engine Emerging?
DraftKings Inc. DKNG delivered one of its strongest iGaming performances in recent years, with third-quarter net revenues climbing 25% year over year, marking the fastest pace since early 2024. This
Is Comfort Systems Positioned for Long-Term Pharma Project Demand?
Comfort Systems USA, Inc. FIX is seeing rising activity across sectors that depend on complex mechanical and electrical systems and one area showing growing visibility is pharma and life sciences
Can Flex Offset Automotive Headwinds in Its Reliability Segment?
Flex Ltd. FLEX is witnessing strong business performance, largely driven by surging demand across its data center and high-value, technology-driven businesses. Even as momentum builds across other
Can PLAY's Revamped Remodel Blueprint Catalyze Its Next Growth Cycle?
Dave & Buster's Entertainment, Inc. PLAY is advancing a more focused and efficiency-oriented remodel strategy that management highlighted as a key component of its Back to Basics plan. In the third
Suncor Unveils 2026 Guidance Focused on Growth & Superior Returns
Suncor Energy Inc. SU has released its 2026 corporate guidance, reinforcing its commitment to operational excellence, disciplined capital allocation and sustained shareholder value creation
GSK Gets FDA Nod for Blujepa in Uncomplicated Urogenital Gonorrhea
GSK plc GSK announced that the FDA has approved its supplemental new drug application (sNDA) seeking approval for its oral antibiotic Blujepa (gepotidacin) for treating uncomplicated urogenital
Here's Why 2026 Could Be a Breakout Year for India ETFs
India’s markets started December with a stumble, with the NIFTY 50 falling about 0.47% month to date. However, the sentiment appears to be shifting. The index, representing 50 of the largest
Will the CEC Acquisition Strengthen Sterling's Margin Profile in 2026?
Sterling Infrastructure, Inc. STRL is taking a meaningful step forward with the acquisition of CEC, expanding capabilities across mission-critical end markets and strengthening its position for
Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?
Merck MRK is focusing on driving its long-term growth with its new products and a promising set of pipeline candidates as its blockbuster PD-L1 inhibitor, Keytruda, faces patent expiration in 2028.
CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution
CeriBell Inc. CBLL recently announced that the FDA has given 510(k) clearance for its latest delirium monitoring solution, making it the one and only FDA-cleared solution for continuous tracking of
Fed Cuts Rate: Will This Accelerate Morgan Stanley's IB Fee Growth?
The Federal Reserve has implemented its third consecutive 25-basis-point rate cut this year, reigniting investor optimism. The move is expected to support the ongoing strong resurgence in
Carnival (CCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Carnival (CCL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended November 2025. This widely-known consensus


